Nasuh C Buyukkaramikli

5PUBLICATIONS
16CO-AUTHORS
HaematologyHealth economicsDesign practice and methodsMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 27, 2020
Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis.

Nigel Armstrong, Nasuh Büyükkaramikli, Hannah Penton

|Sep 09, 2020
A MEA is a MEA is a MEA? Sequential decision making and the impact of different managed entry agreements at the manufacturer and payer level, using a case study for an oncology drug in England.

Nasuh C Buyukkaramikli, Peter Wigfield, Men Thi Hoang

|Nov 10, 2019
TECH-VER: A Verification Checklist to Reduce Errors in Models and Improve Their Credibility.

Nasuh C Büyükkaramikli, Maureen P M H Rutten-van Mölken, Johan L Severens

|Sep 09, 2018
Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Nasuh C Büyükkaramikli, Saskia de Groot, Rob Riemsma

|Nov 01, 2017
Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal.

Nasuh C Büyükkaramikli, Saskia de Groot, Debra Fayter

Pageof 1

Frequent Collaborators

1 joint publications

Nigel Armstrong

1 joint publications

Hannah Penton

1 joint publications

Rob Riemsma

1 joint publications

Pim Wetzelaer